evodiamine has been researched along with Mouth Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lou, Y; Ren, L; Sun, M | 1 |
| Cho, SD; Kim, Y; Lee, JS; Sachita, K; Yu, HJ | 1 |
2 other study(ies) available for evodiamine and Mouth Neoplasms
| Article | Year |
|---|---|
The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Glycation End Products, Advanced; Humans; Mice; Mice, Nude; Mouth Neoplasms; Quinazolines; Receptor for Advanced Glycation End Products; Signal Transduction | 2021 |
In Vitro Assessment of the Anticancer Potential of Evodiamine in Human Oral Cancer Cell Lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Humans; Mitochondria; Morpholines; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Plant Extracts; Poly(ADP-ribose) Polymerases; Protein Transport; Proto-Oncogene Proteins c-akt; Quinazolines | 2015 |